Workflow Orchestration for Peptide Drug Products

Data Characteristics for This Category

Peptide drug product data originates from diverse sources, including public databases (e.g., PubChem, PDB), patent literature, clinical trial reports, and internal experimental data. Data update frequencies vary; public databases might update monthly or quarterly, while clinical trial data generates in real-time with research progress. Document structures typically include peptide sequences (amino acid composition), modification information (e.g., cyclization, non-natural amino acids), synthesis processes, pharmacokinetic (PK) and pharmacodynamic (PD) data, toxicology reports, and formulation details. Key fields include Peptide Sequence, Molecular Weight, Purity (%), Solubility, Storage Condition, CAS Number, and Potency (IC50/EC50). Units involve Daltons (Da), moles (mol), milligrams per milliliter (mg/mL), degrees Celsius (°C), and the same metric might have multiple reporting units.

Constraints Imposed by These Characteristics on "Workflow Orchestration"

The complexity and diversity of peptide sequences require workflows to accurately identify and parse amino acid sequences, such as Xaa-Gly-Pro-Arg-Xbb, during text processing. The presence of modification information necessitates matching and extracting specific string patterns to identify modification types like "N-terminal acetylation." Data scattered across different sources and formats demands robust heterogeneous data access and preprocessing capabilities from the workflow, for example, converting PDF experimental reports into structured text. Pharmacodynamic and toxicological data often contain numerical ranges and units, requiring numerical comparison and calculation nodes within the workflow to handle unit conversions correctly and address missing or inconsistent data. Additionally, given the long development cycle of peptide drugs, data accumulation is an ongoing process, and workflows need to support incremental updates and historical version management.

Configuration Guidelines

Configuration Item	Suggested Value	Rationale for This Value
`Data Source Connector`	Multiple connectors, e.g., `PubMed API`, `InternalLIMS DB`, `Patent Document Storage`	Peptide data comes from various sources; aggregating data from different systems is necessary.
`Text Chunk Size`	`500–800 characters`	Ensures critical structures like peptide sequences and modification information are not truncated, while maintaining semantic integrity.
`Recall count`	`Top 10 entries`	Increases recall in the initial retrieval phase to cover potentially relevant information, with subsequent optimization via re-ranking.
`Similarity threshold`	`0.75`	Balances recall precision and generalization ability, avoiding interference from irrelevant information while capturing sequence and functional similarity.
`AINode System Prompt`	Explicitly specify identification of fields like `Peptide Sequence`, `Purity (%)`, `CAS Number`	Guides the AI to focus on core attributes of peptide products, reducing interference from irrelevant information.
`HTTPRequest timeout`	`600 seconds`	Accommodates potentially long-running computations from external APIs (e.g., structure prediction tools), ensuring requests complete.

Common Pitfalls

Workflow execution timeout, with logs showing HTTP 504 Gateway Timeout: This occurs when external peptide structure prediction or similarity comparison APIs take too long to respond, and the workflow does not set a sufficient waiting time.
Key fields extracted by the AI node (e.g., Purity (%)) are empty or in an incorrect format: The system prompt does not adequately constrain the AI's output format, or it does not provide enough examples to guide the AI in correctly parsing numerical values with units.
Values returned by a tool call are not recognized in subsequent nodes: The tool node's JSON output structure is complex, and subsequent nodes do not correctly configure the JSON Path or Key, leading to an inability to retrieve the desired specific field values.

How to Verify Configuration

Submit queries containing typical peptide sequences and modification information. Check if the workflow correctly identifies and retrieves relevant product information from multiple data sources.
Simulate inputting queries with numerical ranges and different units (e.g., "peptides with purity greater than 98%"). Verify if the workflow accurately handles unit conversion and numerical comparison.
Trace workflow execution logs. Check if each tool call node and AI node outputs as expected, and if critical parameters (e.g., Recall count, Similarity threshold) are effective within their configured ranges.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.